Searchable abstracts of presentations at key conferences in endocrinology

ea0081yi12 | Young Investigator Awards | ECE2022

Role of the transcription factor HHEX in inner adrenal cortex homeostasis and response to progesterone signaling

Dumontet Typhanie , Basham Kaitlin , Lerario Antonio , Bothou Christina , Brixius Bjoern , Turcu Adina F , Beuschlein Felix , Hammer Gary D

The adrenal glands serve as central organs of the endocrine system by producing steroid hormone essential for organismal homeostasis. Mechanisms ensuring proper adrenal homeostasis and function are therefore crucial for maintaining human life. ACTH, released by the pituitary corticotrope, is required for the differentiation of the inner part of the adrenal cortex (the zona fasciculata) and the resultant stimulation of cortisol production. Perturbation of ACTH signaling can lea...

ea0081rc7.6 | Rapid Communications 7: Pituitary and Neuroendocrinology 2 | ECE2022

Long-term results from the Phase III LINC 4 study: Osilodrostat maintained normal mean urinary free cortisol in patients with Cushing’s disease, with a favourable safety profile

Gadelha Monica , Snyder Peter J , Witek Przemysław , Bex Marie , Belaya Zhanna , Turcu Adina F , Feelders Richard , Heaney Anthony , Paul Michaela , Pedroncelli Alberto , Auchus Richard

Background: Osilodrostat (potent oral 11β-hydroxylase inhibitor) provided rapid normalisation of mean urinary free cortisol (mUFC) in Cushing’s disease (CD) patients during the 48-week (W) core period of LINC 4 (NCT02697734) and was well tolerated. We report long-term efficacy and safety results from the LINC 4 core and extension phases.Methods: 73 adults with CD and mUFC >1.3 upper limit of normal (ULN) were enrolled. LINC 4 comprised a 12...

ea0081p413 | Pituitary and Neuroendocrinology | ECE2022

Osilodrostat provides sustained clinical benefits and improves health-related quality of life in patients with cushing’s disease: results from the Phase III LINC 4 study

Feelders Richard , Gadelha Monica , Bex Marie , Witek Przemysław , Belaya Zhanna , Yu Yerong , Turcu Adina F. , Heaney Anthony , Auchus Richard , Piacentini Andrea , Pedroncelli Alberto , Snyder Peter J.

Background: Cushing’s disease (CD) is associated with hypercortisolism-induced cardiovascular morbidity and mortality and impaired patient quality of life (QoL). We report long-term effects of osilodrostat (potent 11β-hydroxylase inhibitor) on cardiovascular/metabolic-related risk factors, physical features of hypercortisolism and QoL in CD patients following the core and extension phases of the LINC 4 study (NCT02697734).Methods: LINC 4 compri...